DR. RITU TRIVEDI
 
 

Scientist
Endocrinology Division
Central Drug Research Institute,
Lucknow-226 001

 
 
Educational Qualifications MSc., PhD (SGPGI, Lucknow)
E-Mail  ritu_trivedi@cdri.res.in
Phone : +91-522-2612411-18 Ext. 4246
Fax:

+91-522-2623405, 2629504

Date of Birth 24.05.1971
 
POST-DOCTORAL RESEARCH EXPERIENCE
 
2000-2002 - National Institute of Health, USA
 
CURRENT AREAS OF INTEREST
• Identification of novel osteogenic agents
• Development of novel delivery system for bone
• Pharmacological targeting of transient PTH release as bone anabolic agents
• Comparative proteomic approach to study the changes in the protein expression profiles of the potential anabolics in osteoblasts

 
SELECTED PUBLICATIONS
 
Trivedi R, Mithal A, Chattopadhyay N. Anabolics in osteoporosis: the emerging therapeutic tool. Curr Mol Med. 10:14-28, 2010
Trivedi R, Mithal A, Chattopadhyay N. Pharmacological manipulation of calcium sensing receptor: Prospect as anabolic therapy for postmenopausal osteoporosis. Drugs of Future, 2009, 34(10): 803-809
Kumar A, Singh AK, Gautam AK, Chandra D, Singh D, Changkija B, Singh MP, Trivedi R. Identification of Kaempferol-Regulated Proteins in Rat Calvarial Osteoblasts during Mineralization by Proteomics. Proteomics 2010 Feb 16
Ritu Trivedi, Avinash Kumar, Varsha Gupta, Sudhir Kumar, Geet. K. Nagar, Jose R. Romero, Anil Kumar Dwivedi, Naibedya Chattopadhyay (2009) Effects of Egb 761 on bone mineral density, bone microstructure, and osteoblast function: Possible roles of quercetin and kaempferol. Mol Cell Endocrinol 302: 86–91
Trivedi R, Kumar S, Kumar A, Siddiqui JA, Swarnkar G, Gupta V, Kendurker A, Dwivedi AK, Romero JR, Chattopadhyay N (2008) Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats. Mol Cell Endocrinol 289 :85-93.
Uma Sharan Singh, Ravi Shankar, Avinash Kumar, Ritu Trivedi, Naibedya Chattopadhyay, Nishi Shakya, Shraddha Palne, Suman Gupta & K Hajela (2008) . Synthesis and Biological Evaluation of Indolyl Bisphosphonates as Anti-bone Resorptive and Antileishmanial Agents. Bioorganic & Medicinal Chemistry, 16: 8482–8491.
Trivedi R, Mithal A, Chattopadhyay N (2008) Recent updates on the Calcium-Sensing Receptor as a Drug Target. Curr Med Chem. 15:178-186.
Tiwari S, Gupta SK, Kumar K, Trivedi R, Godbole MM (2004) Simultaneous exposure of excess fluoride and calcium deficiency alters VDR, CaR, and calbindin D 9 k mRNA levels in rat duodenal mucosa. Calcif Tissue Int. 75:313-320.
Torrado M, Senatorov VV, Trivedi R, Farris RN, Tomarev SI (2004) Pdlim2, a novel PDZ-LIM domain protein interacts with alpha actinin and filamin A. Invest Opthalmol Vis Sci 45: 3955-3963.
Torrado M, Trivedi R, Zinovieva R, Karavanova I, Tomarev SI. (2002) Optimedin: a novel olfactomedin-related protein that interacts with myocilin. Hum Mol Genet. 11(11):1291-301
Book Chapters
Godbole MM, Gupta SK, Trivedi R. Skeletal Growth factors, cytokines and Prostaglandins In: Teotia SPS, Teotia M, editors. Nutritional and Metabolic bone and stone disease: An Asian Perspective, 1st ed. New Delhi: CBS Publishers; 2008. p. 109-118.
Gupta SK, Trivedi R Godbole MM. Matrix Proteins of Bone. In: Teotia SPS, Teotia M, editors. Nutritional and Metabolic bone and stone disease: An Asian Perspective, 1st ed. New Delhi: CBS Publishers; 2008. p. 21-25.
Gupta SK, Trivedi R, Godbole MM. Matrix minerals of bone In: Teotia SPS, Teotia M, editors. Nutritional and Metabolic bone and stone disease: An Asian Perspective, 1st ed. New Delhi: CBS Publishers; 2008. P.26-29